Stability proteins and peptides

Y. J. Wang and M. A. Hanson, Parenteral formulations of proteins and peptides Stability and stabilizers. 

Stevenson, C. L. (2000), Characterization of protein and peptide stability and solubility in non-aqueous solvents, Curr. Pharm. Biotechnol., 1,165-182. 

Bnmmer P M, Koppenol S (2000). Chemical and physical considerations in protein and peptide stability. In E J McNally, (eds.). Protein Formulation and Delivery, Marcel Dekker, Inc. New York, pp. 5-69. 

The specification development process is a data-driven activity that requires a validated analytical method. The levels of data needed include assay precision, replicate process results (process precision), and real-time stability profiles. A statistical analysis of these data is critical in setting a realistic specification. Most often, aggregation and fragmentation degradation mechanisms are common to protein and peptide therapeutics. Therefore, the SE-HPLC method provides a critical quality parameter that would need to be controlled by a specification limit. 

M. Pikal, Freeze drying of proteins Process, formulation, and stability, in Formulation and Delivery of Proteins and Peptides (J. Cleland and R. Langer, eds.), ACS Symposium Series 567, 1993, pp. 120-133. 

The presence of a solvent, especially water, and/or other additives or impurities, often in nonstoichiometric proportions, may modify the physical properties of a solid, often through impurity defects, through changes in crystal habit (shape) or by lowering the glass transition temperature of an amorphous solid. The effects of water on the solid-state stability of proteins and peptides and the removal of water by lyophilization to produce materials of certain crystallinity are of great practical importance although still imperfectly understood. 

Carpenter, J. F., Prestrelski, S. J., Anchordogy, T. J., Arakawa, T. Interaction of stabilizers with proteins during freezing and drying. ACS Symposium Ser. 567 (Formulation and delivery of proteins and peptides), p. 134-147, 1994... 

The selection considerations for appropriate p7 markers for cIEF with proteins/anti bodies included purity and stability of the p7 markers, p7 values of the protein analytes, and potential protein—p7 marker interactions. High purity, stable p7 markers that give reliable p7 values with no protein—p7 marker interaction are desirable. Table 6 lists sets of p7 markers used for optimization. The antibody of interest had a p7 range of approximately 6.3 to 7.0. In this case, six different vendor sources were evaluated. These p7 markers vary in nature, from proteins and peptides to small molecules. The e-grams obtained using these markers with the antibody of interest are shown in Figure 22. Although the nature of the p7 markers and exact p7 marker values were different, the cIFF profiles of the antibody were the same. 

Within the framework of a cooperative research project founded by the EC, a procedure has been developed for the formulation of injectable bio-erodible nanoparticles with fairly uniform size distribution and high environmental stability that appear well suited for targeted administration of protein and peptide dmgs. 

High temperatures can break native S-S bonds and form new S-S bonds which can lock the protein into a denatured eonfiguration [89]. Low pH, sodium dodecyl sulfate. Tween 80, chaotropie salts, and exogenous proteins have been used to protect proteins from thermal inaetivation [90]. Ethylene glycol at 30-50% was used to protect the antiviral activity of P-interferon preparations [91]. Human serum albumin was used in recombinant human interferon-Psei-n which resulted in increased thermal stability [62]. Water-soluble polysaeeharides sueh as dextrans and amylose [92], as well as point-specific (site-directed) mutagenesis [93] have also been used to increase thermal stability of therapeutie proteins and peptides. 

Physical and Chemical Integrity of Proteins. The primary sequence of proteins and peptides is comprised of L-amino acids linked together by covalent amide bonds. Substituent group polarity and/or charge is a critical determinant of secondary and tertiary structure and stability. Secondary structures (a-helices and P-sheets) arise from hydrophobic, ionic, and Van der Waals interactions that fold the primary amino acid chain upon itself. Most therapeutic proteins exhibit tertiary structure vital to functionality and are held together by covalent and noncovalent bonding of secondary structures (Figure 5.2). 

Proteins, peptides, and other polymeric macromolecules display varying degrees of chemical and physical stability. The degree of stability of these macromolecules influence the way they are manufactured, distributed, and administered. Chemical stability refers to how readily the molecule can undergo chemical reactions that modify specific amino-acid residues, the building blocks of the proteins and peptides. Chemical instability mechanisms of proteins and peptides include hydrolysis, deamidation, racemization, beta-elimination, disulfide exchange, and oxidation. Physical stability refers to how readily the molecule loses its tertiary and/or sec-... 

The physiochemically and biologically characterized proteins and peptides are further formulated and subject to stability studies. The goal of these studies is to develop a unique combination of excipients, solution pH, buffer, and container that will produce an optimum dosage form. Biopharmaceutical formulations should be... 

Wang, Y.J. and Pearlman, R., eds. (1993). Stability and Characterization of Protein and Peptide Drugs. Plenum Press, New York. 

Specific formulation strategies need to be employed for macromolecule compounds. An excellent review of protein stability in aqueous solutions has been published by Chi et al. (92). In addition to solution stability of proteins and peptides, aerosolization may result in significant surface interfacial destabilization of these compounds if no additional stabilization excipients are added. This is due to the fact that protein molecules are also surface active and adsorb at interfaces. The surface tension forces at interfaces perturb protein structure and often result in aggregation (92). Surfactants inhibit interface-induced aggregation by limiting the extent of protein adsorption (92). 

The LTQ-FT mass spectrometer was introduced in late 2003 and, as expected, the main application discussed in the literature is for the analysis of proteins and peptides (Johnson et al., 2004 Syka et al., 2004). A recent book chapter (van der Greef et al., 2004) and a review article (Brown et al., 2005) discussed the application of the LTQ-FT to metabolomics. FTMS applications to dmg metabolism are still very new and dmg discovery research laboratories which have recently purchased the instmment are still in the process of developing and validating methods and approaches. A recent publication describes the depth and flexibility of the experimental setup utilizing accurate mass data-dependent exclusion MS" measurements with a LTQ-FT (Tozuka et al., 2005). We have reported several integrated approaches for determination of metabolic stability, characterization of metabolites and metabolic... 

---